Compare · NPWR vs TMO
NPWR vs TMO
Side-by-side comparison of NET Power Inc. (NPWR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- NPWR operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $223.95B, about 538.4x NPWR ($416.0M).
- Over the past year, NPWR is down 11.5% and TMO is up 27.2% - TMO leads by 38.7 points.
- TMO has been more active in the news (14 items in the past 4 weeks vs 9 for NPWR).
- TMO has more recent analyst coverage (25 ratings vs 7 for NPWR).
- Company
- NET Power Inc.
- Thermo Fisher Scientific Inc
- Price
- $1.85-1.60%
- $606.15+0.50%
- Market cap
- $416.0M
- $223.95B
- 1M return
- +17.83%
- +1.10%
- 1Y return
- -11.48%
- +27.22%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 9
- 14
- Recent ratings
- 7
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NPWR
- NET Power Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits
- Net Power Closes Acquisition of EMPower’s Position Under EPC Agreement for 123 MW of Power Generation
- Director Peterson Carol R. was granted 71,770 units of Restricted Stock Units, increasing direct ownership by 69% to 176,151 units (SEC Form 4)
- Director Veltmann Alejandra was granted 71,770 units of Restricted Stock Units, increasing direct ownership by 69% to 176,151 units (SEC Form 4)
- Director Kelliher Joseph T was granted 71,770 units of Restricted Stock Units, increasing direct ownership by 69% to 176,151 units (SEC Form 4)
- Director Alexander Ralph was granted 71,770 units of Restricted Stock Units, increasing direct ownership by 69% to 176,151 units (SEC Form 4)
- Large owner Npeh, Llc sold $463,333 worth of shares (242,900 units at $1.91), decreasing direct ownership by 20% to 1,000,000 units (SEC Form 4)
- Large owner 8 Rivers Capital, Llc sold $463,333 worth of shares (242,900 units at $1.91) (SEC Form 4)
- Net Power Signs Agreements for Additional Power Generation to Advance its Power-First Strategy
- Large owner Npeh, Llc sold $1,395,933 worth of shares (757,100 units at $1.84), decreasing direct ownership by 38% to 1,242,900 units (SEC Form 4)
Latest TMO
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026